BROOKLYN PREWITT: Open Payments
NPI 1821609173 · BARBOURVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,174 in 117 payments from 21 companies in 2025. Trend: 2023 $636 · 2024 $1,465 · 2025 $2,174
Food & beverage: $2,174
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $328 |
| Insulet Corporation | 20 | $280 |
| Shionogi Inc | 18 | $242 |
| Paratek Pharmaceuticals, Inc. | 10 | $231 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $199 |
| ABBVIE INC. | 8 | $174 |
| Melinta Therapeutics, LLC | 6 | $128 |
| Merck Sharp & Dohme LLC | 6 | $109 |
| Tandem Diabetes Care, Inc. | 5 | $92 |
| SANOFI-AVENTIS U.S. LLC | 4 | $78 |
Products named: Omnipod, Fetroja, NUZYRA, Ozempic, JARDIANCE, Rezzayo, ZERBAXA, Rybelsus.
Industry payments across KY — which companies pay providers there.
